Ibrutinib as Neoadjuvant Therapy in Localized Prostate Cancer

NCT02643667 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Ibrutinib
PROCEDURE: Radical prostatectomy

Sponsor

Washington University School of Medicine

Collaborators

[object Object]